Where does Hanmi Pharm. Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Hanmi Pharm. Co., Ltd. ranks #3,774 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Hanmi Pharm. Co., Ltd. hold?

Hanmi Pharm. Co., Ltd. holds 96 US utility patents granted between 2015 and 2025, spanning 18 technology areas.

What is Hanmi Pharm. Co., Ltd.'s Innovation Score?

Hanmi Pharm. Co., Ltd. has an Innovation Score of 43.5 out of 100 (top 28% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Hanmi Pharm. Co., Ltd. focus on?

Hanmi Pharm. Co., Ltd.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 82 patents. Grants appear in 18 CPC subclasses total.

Is Hanmi Pharm. Co., Ltd.'s patent grant rate increasing or decreasing?

Hanmi Pharm. Co., Ltd.'s recent grant velocity is -2% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Hanmi Pharm. Co., Ltd.'s patents?

Hanmi Pharm. Co., Ltd.'s patents average 15.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Hanmi Pharm. Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Hanmi Pharm. Co., Ltd.

USPTO PatentsView assignee record - 96 granted patents across 18 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Hanmi ranks #3,774 of 49,997 tracked US assignees by granted-patent volume, with 96 patents across 18 technology areas.

#3,774
of 49,997 US assignees by volume: Top 28%
by Innovation Score (43.5/100): 15.2
avg claims per patent: -2%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3774 · Foreign Corporation #3,774 · 96 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 96 grants
TOP-DECILE #3,774/49,997
PHOTO-FINISH Dover Europe Sàrl
CPC-FOCUS A61K · 18 areas
INNOV-PAR 43.5/100
CLAIMS-RICH 15.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT -2% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Dover Europe Sàrl (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Theranos · near

44
7980302 Canada · near

43
Hanmi Pharm · this assignee

43
Hyundai America… · near

43
Moteurs Leroy-Somer · near

43
3D Lighting… · lowest

7

What this shows Hanmi's Innovation Score is 43.5/100 (top 28% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Hanmi's grants concentrate

Hanmi Pharm. Co., Ltd. is a focused PatentsView assignee: 18 CPC subclasses with 85.4% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2019 (17 grants) versus a trough of 2 in 2015. By volume, Hanmi sits between Dover Europe Sàrl and John Bean Technologies Corporation.

Hanmi's three-year grant acceleration

From 2019–2021 to 2022–2024, Hanmi Pharm. Co., Ltd. moved from 39 to 21 grants (0.54x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Dover Europe Sàrl

96
Erico Internation…

96
Federal Express

96
Floricultura

96
Hellermanntyton

96
Hallmark Cards In…

96
J Morita MFG

96
John Bean

96
Hanmi Pharm ◀

96

What this shows Hanmi holds 96 patents at rank #3,773, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Hanmi

By rank, the assignees closest to #3,773 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Hanmi's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Hanmi, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (43 here).

Moteurs Leroy-Somer 43 Hyundai America Technical Center Inc. 43 7980302 Canada Inc. 43 Theranos, Inc. 44

Similar claim depth

Nearest assignees by average claims per patent (15.2 here).

Leidos, Inc. 15.2 avg Samson Aktiengesellschaft 15.2 avg Basf Agro B.V. 15.2 avg Cameron Solutions, Inc. 15.2 avg

Hanmi's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 28% higher than 72% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Hanmi Pharm. Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	2.1%
2016	6	6.3%
2017	9	9.4%
2018	10	10.4%
2019	17	17.7%
2020	5	5.2%
2021	17	17.7%
2022	10	10.4%
2023	7	7.3%
2024	4	4.2%
2025partial year	9	9.4%

Which technologies does Hanmi Pharm. Co., Ltd. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 82

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 72

C07K - Peptides 48

C07D - Heterocyclic Compounds 26

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 9

C07C - Acyclic OR Carbocyclic Compounds 4

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 4

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 4

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

C08L - Compositions OF Macromolecular Compounds 2

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 2

C08B - POLYSACCHARIDES; Derivatives Thereof 2

B01D - Separation 2

C12Y - Enzymes 1

Top 15 of 18 technology areas

Where it ranks

Overall rank by patents

#3,774

of 49,997 tracked assignees

Innovation Score

43.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Hanmi Pharm. Co., Ltd.'s patent record in context - here's where to go next.

Hanmi Pharm. Co., Ltd.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 85.4% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #3,774 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Hanmi Pharm. Co., Ltd. against Dover Europe Sàrl, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.